These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2869819)

  • 1. Biochemical studies of nerve cells and energy metabolism in Alzheimer's disease.
    Bowen DM; Davison AN
    Br Med Bull; 1986 Jan; 42(1):75-80. PubMed ID: 2869819
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alzheimer's disease and neurotransmitters].
    Nakamura S
    Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):30-40. PubMed ID: 1672465
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurotransmitters of the cerebral cortex in senile dementia of Alzheimer type.
    Rossor MN; Emson PC; Mountjoy CQ; Roth M; Iversen LL
    Exp Brain Res; 1982; Suppl 5():153-7. PubMed ID: 6129994
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ageing and neurotransmitters].
    Nakamura S; Miyata S
    Nihon Naika Gakkai Zasshi; 1985 Oct; 74(10):1348-52. PubMed ID: 2869092
    [No Abstract]   [Full Text] [Related]  

  • 5. An update on the neurochemistry of Alzheimer disease.
    Davies P
    Adv Neurol; 1983; 38():75-86. PubMed ID: 6137134
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
    Davies P
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427
    [No Abstract]   [Full Text] [Related]  

  • 7. Alzheimer's disease.
    Gottfries CG
    Gerontology; 1986; 32 Suppl 1():98-101. PubMed ID: 2874102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
    Pearce BR; Palmer AM; Bowen DM; Wilcock GK; Esiri MM; Davison AN
    Neurochem Pathol; 1984-1985 Winter; 2(4):221-32. PubMed ID: 6085697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical measurements in Alzheimer's disease reveal a necessity for improved neuroimaging techniques to study metabolism.
    Najlerahim A; Bowen DM
    Biochem J; 1988 Apr; 251(1):305-8. PubMed ID: 3390157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease.
    Yates CM; Simpson J; Gordon A
    Neurosci Lett; 1986 Apr; 65(2):189-92. PubMed ID: 2940479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease and the new neuroscience.
    Wortis J
    Biol Psychiatry; 1983 Aug; 18(8):847-8. PubMed ID: 6137248
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurotransmitters and second messengers in aging and Alzheimer's disease.
    Francis PT; Webster MT; Chessell IP; Holmes C; Stratmann GC; Procter AW; Cross AJ; Green AR; Bowen DM
    Ann N Y Acad Sci; 1993 Sep; 695():19-26. PubMed ID: 7902054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolism of some neurotransmitters in ageing and dementia disorders.
    Gottfries CG
    Gerontology; 1982; 28 Suppl 2():11-9. PubMed ID: 6131853
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurotransmitter changes in early- and late-onset Alzheimer-type dementia.
    Arai H; Ichimiya Y; Kosaka K; Moroji T; Iizuka R
    Prog Neuropsychopharmacol Biol Psychiatry; 1992; 16(6):883-90. PubMed ID: 1381103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of neurotransmitter abnormalities in Alzheimer's disease.
    Katzman R; Brown T; Fuld P; Thal L; Davies P; Terry R
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():279-86. PubMed ID: 2873637
    [No Abstract]   [Full Text] [Related]  

  • 16. Choline in Alzheimer's disease.
    Spillane JA; Goodhart MJ; White P; Bowen DM; Davison AN
    Lancet; 1977 Oct; 2(8042):826-7. PubMed ID: 71636
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.
    Francis PT; Palmer AM; Sims NR; Bowen DM; Davison AN; Esiri MM; Neary D; Snowden JS; Wilcock GK
    N Engl J Med; 1985 Jul; 313(1):7-11. PubMed ID: 2582256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurotransmitter abnormalities in the dementia of Alzheimer type].
    Sasaki H; Arai H
    Rinsho Shinkeigaku; 1986 Dec; 26(12):1290-3. PubMed ID: 2881639
    [No Abstract]   [Full Text] [Related]  

  • 19. Alzheimer's disease: low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism.
    Tamminga CA; Foster NL; Fedio P; Bird ED; Chase TN
    Neurology; 1987 Jan; 37(1):161-5. PubMed ID: 2879258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical changes in the cholinergic system of the ageing brain and in senile dementia.
    Bowen DM; Davison AN
    Psychol Med; 1980 May; 10(2):315-9. PubMed ID: 6104344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.